.On the heels of an FDA denial for its primary rival Novo Nordisk, Eli Lilly is pushing on in the na...
.Merely a few months after dosing the 1st individual in a phase 2 trial for newly diagnosed glioblas...
.Eli Lilly's look for excessive weight targets has actually led it to the dark genome. The Big Pharm...
.Toolbox Biosciences is actually going on up. The cell therapy business has added $325 million in am...
.After raising $170 million back in February, metabolic disease-focused BioAge Labs has filed to deb...
.Aelis Farma's hopes of getting a simple, positive decision on a $100 million choice repayment have ...
.ProKidney has stopped some of a pair of period 3 trials for its own tissue therapy for renal diseas...
.Vaxcyte unveiled what analysts referred to as "magnificent" stage 1/2 information for its 31-valent...
.Recursion has discovered by means of an early exam of its tech-enabled approach to drug exploration...
.Call it a scenario of good chemical make up: Acepodia, a biotech based on Nobel Champion science, i...